Cytokinetics
CYTK | NASDAQ
$67.62
-$1.16 (-1.69%)
Sep 21, 2026, 12:48 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -9.72 | -8.94 | -15.32 | -10.58 | -16.28 | -10.55 |
PEG Ratio | -0.40 | 2.57 | -0.59 | -0.19 | -0.39 | 0.44 |
PS Ratio | 86.62 | 285.13 | 1.07K | 43.51 | 49.76 | 24.02 |
PB Ratio | -11.56 | -38.91 | -20.86 | -38.14 | 14.37 | 11.83 |
P/FCF Ratio | -14.26 | -13.18 | -19.38 | -13.24 | -18.31 | -635.76 |
P/OCF Ratio | -14.95 | -13.31 | -19.45 | -13.74 | -24.59 | 149.93 |
OCF/S Ratio | -579.30 | -2.14K | -5.5K | -316.65 | -202.37 | 16.02 |
Debt / Equity Ratio | -1.95 | -5.83 | -1.96 | -6.95 | 1.11 | 1.23 |
Quick Ratio | 4.53 | 6.17 | 6.12 | 9.40 | 7.45 | 15.20 |
Current Ratio | 4.53 | 6.17 | 6.12 | 9.40 | 7.45 | 15.20 |
Asset Turnover | 0.06 | 0.01 | 0.01 | 0.09 | 0.08 | 0.10 |
Interest Coverage | -5.89 | -6.20 | -8.60 | -6.34 | -6.35 | -2.43 |
Return on Equity | 119% | 435.49% | 136.22% | 360.48% | -88.29% | -112.27% |
Return on Assets | -55.10% | -42.06% | -63.84% | -38.33% | -25.59% | -23.85% |
Return on Invested Capital | -47.74% | -42.81% | -66.20% | -34.35% | -23.75% | -18.59% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 88.50% | -1.74K% | -4.28K% | -154.59% | -127.09% | -73.66% |
Net Profit Margin | -891.60% | -3.19K% | -6.99K% | -411.21% | -305.72% | -228% |
Pretax Profit Margin | -891.60% | -3.19K% | -6.99K% | -411.21% | -305.72% | -228% |
Operating Profit Margin | -695.44% | -2.9K% | -6.59K% | -342.75% | -264.54% | -168.27% |
FCF Margin | -607.48% | -2.16K% | -5.52K% | -328.64% | -271.76% | -3.78% |
EBITDA Margin | -880.60% | -2.67K% | -6.06K% | -348.25% | -250.39% | -155.45% |
Add to Watchlist
Select watchlists to add or remove CYTK